Despite having one of the most advanced healthcare systems in the world, Switzerland is now ranked sixth in Europe for innovative drug access and ninth for…
In Conversation
The opportunities here are real, and the success we have seen in manufacturing serves as a testament to what can be achieved in other sectors, including…
Swissmedic is well-equipped to address the challenges in the ATMP field and is ready to help shape the future of drug regulation
Our goal is to make Switzerland the number one medtech market in the world by driving innovation and attracting investment
While Puerto Rico is known for its beauty and favourable climate, what truly sets us apart is our talent
AMR is important today, but the bigger issue is what could happen in the future
Ultimately, the combination of our talent pool, robust infrastructure, supportive policies, and innovative technologies positions Puerto Rico as an attractive destination for biosciences companies
The pro-innovation environment and robust support for R&D are key reasons why Switzerland remains such a vital part of MSD’s global strategy. Our continued investment reflects…
The foundation for a successful investment project is laid in the very early stages, with the right setup and a solid organization
We must secure a sustainable future where innovation and patient care thrive together
Keep Stragen on your radar, especially regarding the pressing issue of drug shortages, which will become increasingly significant in the next few years
At the end of the day, it’s all about people—their energy, ideas, and collaboration. People are the heart of Menarini’s values
